Guardant Health, a Palo Alto-based company, gained approval from the Food and Drug Administration on a first-of-its-kind blood test to be used for colorectal cancer screenings this month, which is now commercially available.
Guardant Health, a Palo Alto-based company, gained approval from the Food and Drug Administration on a first-of-its-kind blood test to be used for colorectal cancer screenings this month, which is now commercially available.
